| Literature DB >> 31534352 |
Yanhong Shang1,2, Dexi Li2, Xinxin Shan2, Stefan Schwarz3, Su-Mei Zhang2, Yu-Xia Chen2, Wuqing Ouyang1, Xiang-Dang Du2.
Abstract
Background: The acquired optrA gene, which encodes a ribosomal protection protein of the ABC-F family, can confer cross-resistance to linezolid and florfenicol, posing a serious therapeutic challenge to both human and veterinary medicine. Purpose: The objective of this study was to investigate the two Enterococcus faecalis (E. faecalis) plasmids for their fine structure, their transferability and the presence of mobile antimicrobial resistance loci.Entities:
Keywords: IS1216; conjugation; enterococci; mobile genetic elements; resistance
Year: 2019 PMID: 31534352 PMCID: PMC6682170 DOI: 10.2147/IDR.S206295
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
PCR primers used in this study
| Category and gene | Primer designation | Sequence (5ʹ-3ʹ) | Product size(bp) | Reference or source |
|---|---|---|---|---|
| GCACCAGACCAATACGATACAA | 794 | This study | ||
| TCCTTCTTAACCTTCTCCTTCTCA | ||||
| circ-I-fw | TATCAAGCGAAATATGCAGG | 4,052 | This study | |
| circ-I-rv | TGCACCATTTTAGCTTTCGT | |||
| circ-II-fw | AAATGGGTATGGGCAATATG | 4,633 | This study | |
| circ-II-rv | ATCGCTTGTGGGCTATATCA | |||
| Tn | circ-III-fw | CGGTGCCTAATCATTCGTATGC | 11 | |
| circ-III-rv | CGCTTAACCGGTTCTATCACTTCA | |||
| circ-IV-fw | TGCACATACTTGAAACCTCC | 3,601 | This study | |
| circ-IV-rv | CTTGAACTACTGATTCTCGG | |||
| circ-V-fw | TGCCACACTATCATAACCACT | 3,227 | This study | |
| circ-V-rv | ACTTTTAATTCTAGCGTGCCT |
The antimicrobial susceptibilities of the wild-type strains, transconjugants, and recipient strains in this study
| Strains | MICs(mg/L)a | ||||
|---|---|---|---|---|---|
| FFC | LZD | BAC | GEN | TET | |
| E211 | 128 | 8 | 128 | >128 | 128 |
| E211-T1b | 128 | 8 | 128 | 8 | 1 |
| E508 | 128 | 8 | 4 | >128 | 128 |
| E508-T1b | 128 | 8 | 2 | >128 | 64 |
| JH2-2 | 4 | 2 | 2 | 8 | 1 |
Notes: aFFC, florfenicol; LZD, linezolid; TET, tetracycline; GEN, gentamicin; BAC, bacitracin. bThe transconjugants E211-T1 and E508-T1 were derived from matings between E. faecalis strains E211/E508 and JH2-2, respectively.
Comparison the difference of OptrA variants and MICs with wide-type strain
| Strain | OptrA variant | Amino acid substitutions | MICs of linezolid (mg/L) | References |
|---|---|---|---|---|
| E349 | Wide-type | none | 8 | 4 |
| E211 | ED | K3 | 8 | This study |
| E508 | DP | Y176 | 8 | This study |
Figure 1The structure of two pheromone-responsive conjugative multiresistant plasmids carrying a mobile optrA locus from E. faecalis in this study (A) The structure of the plasmid pE211. The positions of two mobile elements (MGE1 and MGE2), and Tn558 were indicated in bold vertical lines and arrows outside the plasmid, (B) The structure of the plasmid pE508. The positions of two mobile elements (MGE3 and MGE4) were indicated in bold vertical lines and arrows outside the plasmid. The circles display (from the outside to inside): (i) the size scale in bp; (ii) the positions of predicted coding sequences transcribed in the clockwise orientation; (iii) the positions of predicted coding sequences transcribed in the counterclockwise orientation; (iv) the GC content plotted against 50%, with orange indicating >50% and purple indicating <50%; and (v) GC skew [(G-C)/(G+C)] in a 10,000 bp window. Genes are colour-coded, depending on functional annotations: blue, transposition; red, antimicrobial resistance; green, other function; gray, hypothetical protein.
Figure 2The environment of the optrA gene in different plasmids.
Coding sequences of the plasmid pE211
| CDS no. | CDS | Nucleotide position (5ʹ→3ʹ) | Protein length (aa) | Database match (Size and accession no.) | aa identify (%) |
|---|---|---|---|---|---|
| 1 | 1–1008 | 335 | replication initiator protein A, | 99.7% (334/335) | |
| 2 | 1358–2305 | 315 | ATPase, | 99.7% (314/315) | |
| 3 | 4303–4971 | 222 | CPBP family intramembrane metalloprotease, | 99.5% (221/222) | |
| 4 | 6038–6658 | 206 | resolvase, N-terminal domain protein, | 97.6% (206/211) | |
| 5 | IS | 6830–7516 | 232 | IS | 100.0% (232/232) |
| 6 | 8026–9453 | 475aa | chloramphenicol/florfenicol efflux MFS transporter FexA, | 100.0% (475/475) | |
| 7 | 9631–10,047 | 138 | putative oxidoreductase, | 100.0% (138/138) | |
| 8 | 10,330–10,695 | 121 | Transposase C, | 100.0% (121/121) | |
| 9 | 10,697–12,616 | 639 | Transposase B, | 100.0% (639/639) | |
| 10 | 12,613–13,698 | 361 | Transposase A, | 100.0% (361/361) | |
| 11 | 15,103–15,726 | 207 | resolvase helix-turn-helix protein, | 100.0% (207/207) | |
| 12 | IS | 17,617–18,297 | 226 | IS | 100.0% (226/226) |
| 13 | 18,886–20,040 | 384 | AraC family transcriptional regulator, | 100.0% (383/384) | |
| 14 | 20,371–22,338 | 655 | ABC-F type ribosomal protection protein OptrA, | 99.7% (653/655) | |
| 15 | 23,967–28,367 | 1466 | restriction endonuclease, Enterococcaceae bacterium (1466aa, QBA99712.1) | 100.0% (1466/1466) | |
| 16 | IS | 29,642–30,322 | 226 | IS | 100.0% (226/226) |
| 17 | 30,735–31,376 | 213 | Hypothetical protein, | 100.0% (213/213) | |
| 18 | 31,758–33,086 | 442 | Hypothetical protein, | 99.8% (441/442) | |
| 19 | 33,195–34,076 | 293 | DNA nuclease, | 100.0% (293/293) | |
| 20 | 34,048–34,491 | 147 | Hypothetical protein, | 100.0% (147/147) | |
| 21 | 34,705–35,541 | 278 | Hypothetical protein, | 99.6% (277/278) | |
| 22 | 36,916–37,392 | 158 | Single-strand binding protein, | 100.0% (158/158) | |
| 23 | 37,532–38,872 | 446 | Hypothetical protein, | 99.6% (444/446) | |
| 24 | 38,863–39,639 | 258 | Hypothetical protein, | 100.0% (258/258) | |
| 25 | 47,434–49,998 | 846 | Type VI secretion protein, | 99.8% (844/846) | |
| 26 | 51,750–52,784 | 344 | Conjugal transfer protein, | 100.0% (344/344) | |
| 27 | 54,111–55,382 | 423 | CHAP domain-containing protein, | 100.0% (423/423) | |
| 28 | 56,288–57,166 | 292 | Hypothetical protein, | 100.0% (292/292) | |
| 29 | 58,328–62,218 | 1296 | aggregation substance, Enterococcaceae bacterium (1296aa, QBA99726.1) | 100.0% (1296/1296) | |
| 30 | 63,454–66,174 | 906 | LPXTG-motif cell wall anchor domain protein, | 100.0% (906/906) | |
| 31 | 68,199–69,158 | 319 | Conjugal transfer protein TraA, | 100.0% (319/319) | |
| 32 | IS | 69,902–70,582 | 226 | IS | 100.0% (226/226) |
| 33 | 70,779–71,609 | 276 | Undecaprenyl-diphosphatase, | 100.0% (276/276) | |
| 34 | 71,609–72,310 | 249 | bacitracin ABC transporter permease, | 100.0% (249/249) | |
| 35 | 72,351–73,268 | 305 | bacitracin ABC transporter, ATP-binding protein BcrA, | 100.0% (305/305) | |
| 36 | 73,451–74,065 | 204 | XRE family transcriptional regulator, | 100.0% (204/204) | |
| 37 | IS | 74,621–75,301 | 226 | IS | 100.0% (226/226) |
Abbreviations: hp, hypothetical protein; aa, amino acids.
Coding sequences of plasmid pE508
| CDS no. | CDS | Nucleotide position (5ʹ→3ʹ) | Protein length (aa) | Database match (Size and accession no.) | aa identify (%) |
|---|---|---|---|---|---|
| 1 | 140–1600 | 486 | Hypothetical protein, | 100.0%(486/486) | |
| 2 | 3025–3753 | 242 | Hypothetical protein, | 100.0% (242/242) | |
| 3 | 10,688–11,188 | 166 | DnaJ domain-containing protein, partial, | 95.4% (165/173) | |
| 4 | 12,574–13,359 | 261 | ArsR family transcriptional regulator, | 100.0% (261/261) | |
| 5 | 14,217–16,430 | 737 | hypothetical protein, | 99.3% (732/737) | |
| 6 | 16,417–18,579 | hypothetical protein, | 100.0% (720/720) | ||
| 7 | 19,135–21,627 | 830 | type VI secretion protein, | 98.1% (830/846) | |
| 8 | 23,001–24,035 | 344 | conjugal transfer protein, | 99.7% (343/344) | |
| 9 | 24,742–25,359 | 205 | Hypothetical protein, | 99.5% (204/205) | |
| 10 | 25,362–26,633 | 423 | CHAP domain protein, | 100.0% (423/423) | |
| 11 | 27,539–28,417 | 292 | Hypothetical protein, | 100.0% (292/292) | |
| 12 | 29,580–33,497 | 1305 | LPXTG cell wall anchor domain-containing protein, | 99.6% (1300/1305) | |
| 13 | 34,280–37,003 | 907 | Surface exclusion protein, Enterococcaceae bacterium (907aa, QBA99747.1) | 100.0% (907/907) | |
| 14 | 39,968–41,557 | 529 | TraC protein, | 99.4% (526/529) | |
| 15 | 41,607–42,764 | 385 | TraB/GumN family protein, | 100.0% (385/385) | |
| 16 | 42,934–43,944 | 336 | replication initiator protein A, | 100.0% (336/336) | |
| 17 | 44,553–45,335 | 260 | ParA family protein, | 100.0% (260/260) | |
| 18 | 46,984–48,300 | 438 | Y-family DNA polymerase, | 100.0% (438/438) | |
| 19 | 48,617–50,647 | 669 | Hypothetical protein, | 99.2% (664/669) | |
| 20 | IS | 52,601–53,287 | 228 | IS | 100.0% (228/228) |
| 21 | IS | 53,912–55,084 | 390 | IS | 99.7% (389/390) |
| 22 | 55,214–56,653 | 479 | bifunctional aminoglycoside N-acetyltransferase/aminoglycoside phosphotransferase, | 100.0% (479/479) | |
| 23 | IS | 57,683–58,369 | 228 | IS | 100.0% (228/228) |
| 24 | 60,449–61,876 | 475 | Florfenicol/chloramphenicol exporter, | 99.8% (474/475) | |
| 25 | 63,385–63,990 | 201 | Hypothetical protein, | 100.0% (201/201) | |
| 26 | 65,562–66,395 | 277 | GIY-YIG nuclease family protein, | 99.6% (276/277) | |
| 27 | 68,095–69,273 | 392 | Replication initiator protein, | 100.0% (392/392) | |
| 28 | IS | 70,722–71,408 | 228 | IS | 100.0% (228/228) |
| 29 | 71,967–73,343 | 458 | tetracycline efflux MFS transporter Tet(L), | 99.8% (457/458) | |
| 30 | 74,006–75,925 | 639 | tetracycline resistance ribosomal protection protein, | 100.0% (639/639) | |
| 31 | IS | 76,939–77,619 | 228 | IS | 100.0% (228/228) |
| 32 | 78,123–80,090 | 655 | ABC-F type ribosomal protection protein OptrA, | 99.8% (654/655) | |
| 33 | 81,507–82,238 | 242 | 23S rRNA (adenine(2058)-N(6))-methyltransferase Erm(A), | 100.0% (242/242) | |
| 34 | IS | 83,691–84,377 | 228 | IS | 100.0% (228/228) |
Abbreviations: hp, hypothetical protein; aa, amino acids.